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Summary. The influence of successful 
simultaneous pancreas and kidney transplantation on 
peripheral polyneuropathy was investigated in 53 
patients for a mean observation period of 40.3 
months. Seventeen patients were followed-up for 
more than 3 years. Symptoms and signs were 
assessed every 6 months using a standard 
questionnaire, neurological examination and 
measurement of sensory and motor nerve conduction 
velocities. While symptoms of polyneuropathy 
improved (pain, paraesthesia, cramps, restless-legs) 
and nerve conduction velocity increased, there was 
no change of clinical signs (sensation, muscle-force, 
tendon-reflexes). Following kidney-graft-rejection 
there was a slight decrease of nerve conduction 
verlocity during the first year, which was not 
statistically significant. Following pancreas-graft 
rejection there was no change of nerve conduction 
velocity during the first year. Comparing the 
maximum nerve conduction velocity of the patients 
with pancreas-graft-rejection o the nerve conduction 
velocities of these patients at the end of the study, 
there was a statistically significant decrease of 6.5 
m/s. 
In conclusion, we believe that strict normalization of 
glucose metabolism alters the progressive course of 
diabetic polyneuropathy. It may be stabilized or 
partly reversed after successful grafting even in long- 
term diabetic patients. 
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Introduction 
The main goal of combined pancreas and kidney 
grafting in patients with long-standing diabetes 
meUitus is to improve secondary complications. 
There is some evidence that strict control of 
hyperglycaemia may favourably influence the course 
of diabetic complications such as neuropathy, but 
data remain conflicting (Dyck et al. 1986; Unger 
1982). Pancreatic transplantation allows the 
normalization ofglucose metabolism in most patients 
(Landgraf et al. 1987). Only few data exist, if this 
procedure, which is only performed at an advanced 
stage of the disease, is able to reverse diabetic 
neuropathy (Van der Vliet et al. 1988; Solders et al. 
1987; Kennedy et al. 1990). 
The purpose of our study was to investigate the 
influence of successful pancreas and kidney grafting 
and of graft rejection on diabetic polyneuropathy in 
Type i insulin-dependent diabetic patients. 
Subjects and methods 
Subjects. We examined 53 patients (25 male, 28 female) with a 
mean age of 35.1 years (23 - 53). All patients had long standing 
Type 1 diabetes mellitus (mean duration 20.8 years) and end- 
stage renal disease with haemodialysis or peritoneal dialysis. They 
had undergone combined pancreas and kidney grafting. Details 
such as selection criteria, operative and post-operative 
management and immuno-suppressive protocols have been 
published previously (Land et al. 1987). The mean observation 
period following trans-plantation was 40.3 months (13.4 - 97 
months). 
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Of these patients 9 lost the the function of their kidney-graft 
alone or before loosing that of the pancreas graft. Graft rejection 
occurred at a mean interval of 30.4 months after the 
transplantation (1 - 67.6 months). These patients were followed- 
up for a mean period of 13.9 months (1 - 23.6) after the 
reoccurrence of uraemia. They were excluded from the study 
when they also lost the function of their pancreas graft. This 
occurred after an average of 20 months (4 - 33) following the start 
of dialysis. 
Fourteen patients with isolated loss of function of the pancreas 
graft were investigated for a mean time of 20.8 months (4 - 58.4) 
after graft rejection. Pancreas graft rejection occurred 17.3 
months (0.3 - 59.2) after the transplantation. One patient lost the 
function of his kidney graft 16 months later. 
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Results 
Symptoms and signs of neuropathy 
Before transplantation 61% of the patients had at 
least one symptom of neuropathy (Table 1). 
Symptoms were mild in 62 %, moderate to severe in 
38 %. 
Following transplantation symptoms of 8 % of the 
symptomatic patients remained unchanged, 50 % 
improved and 42 % became asymptomatic. 
Symptoms reoccurred in 22 % of these patients at an 
interval between 2 and 4 years despite normal graft 
function. 
Methods. Most patients were examined every 6 months following 
transplantation. The first examination after transplantation, 
which we chose as a baseline, was performed 4.4 months after the 
transplantation. By using this method we hoped to get results 
which were not influenced by the release of uraemia but by the 
normalisation of blood glucose levels. 
Symptoms and signs of polyneuropathy were assessed using a 
standardized questionnaire and a neurological examination 
protocol at every visit. 
Signs of polyneuropathy were defined as mild, if there was only a 
diminution or loss of tendon reflexes or an impairment of nly 
one sensory modality at the foot. Signs were moderate, if there 
was an impairment of more than one sensory modality at the foot 
or more proximal sensory disturbances. Ataxia or impairment of 
more than one sensory modality in the proximal segments of the 
limb was defined as severe polyneuropathy. 
Using surface stimulation and registration electrodes motor nerve 
conduction velocities of the right median and peroneal nerve and 
sensory nerve conduction velocities of the distal right median and 
of the distal sural nerve (ankle to foot) were measured. If 
necessary an averager was used to obtain a sensory action 
potential. 
The parameters used were nerve conduction velocities (NCV), 
distal latencies (DL) and amplitudes of sensory nerve action 
potentials (SNAP). 
An electromyographic examination was only done at the entry to 
the study but not during the follow-up period. 
Table 1: Symptoms of polyneuropathy 
Before 2 years after 
transplantation transplantation 
Pain 18 % 12 % 
Cramps 26 % 13 % 
Paraesthesia 48 % 8 % 
Restless legs 5 % 5 % 
Neurological examination at the beginning of the 
study was normal in 9 % of the patients. Minimal 
signs of polyneuropathy were found in 39 %, they 
were moderate in 39 % and severe in 13 %. The 
most common clinical signs were an absent or 
diminished achilles tendon reflex in 92 % and 
pallhypaesthesia in 62 %. Gait ataxia was seen in 15 
%. 
There was no significant change of muscle force, 
sensory deficits or tendon reflexes. 
During the follow-up period 26 % of the patients 
developed symptomatic carpal tunnel syndrome 
(CTS). CTS was unilateral in 9 %, bilateral in 17 %. 
Surgical decompression of the ligament carpi 
transversum was only necessary in one patient. 
Statistical analysis. The statistical analysis of clinical and 
neurophysiological data was done using the paired t- test. The 
level of significance was set at p < 0.05. We compared the 
intraindividual variation between the first examination and the 
end of years 1, 2 and, if the grafts survived, year 3. In the patients 
with isolated loss of function of either the pancreas- or kidney- 
graft, we compared the data of the last examination before to 
those 1/2 and 1 year after graft rejection. 
Electrophysiological studies 
At the beginning of the study the extensor digitorum 
brevis muscle (edb) was denervated in 20 % of the 
patients. No sensory compound action potential of
the distal sural nerve could be measured in 69 %. 
During the follow-up period in one patient 
reinnervation of the edb was observed, in one patient 
denervation occurred. There was no reinnervation of 
the sural nerve. 
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During the follow-up eriod motor peroneal nerve 
conduction velocities of those patients, whose edb 
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muscle was not denervated, increased by an average 
of 6.6 m/s (p < 0.002)(Fig. 1). The increase was _~ 00 
significant after the second year. There was a " so 
significant difference of median motor NCVs ~ o 
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velocities increased by 6.6 m/s between the first lo 
examination and three years after the transplantation o 
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the level of significance. 
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Fig. 2: Peroneal and median NCVs following kindney graft 
rejection (* = p < 0.05, n.s. = p > 0.05)(o = median motor 
nerve, o = peroneal motor  nerve) 
Following pancreas graft rejection in 31% of the 
patients symptoms reoccurred or worsened. Despite 
rejection of the pancreas graft there was a mean 
increase of peroneal nerve conduction velocities of 
4.9 m/s, which was not statistically significant. 
Median nerve conduction velocities decreased at an 
average of 1.5 m/s. (Fig. 3). 
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Fig. 1: Nerve conduction velocities in patients with functioning 
pancreas and kidney grafts (* = p < 0.05, n.s. = p > 0.05)(o = 
median motor  nerve, o = peroneal motor  nerve, 9 = sural nerve) 
NCVs of the sensory median nerve did not increase 
significantly. The patients with symptoms of a carpal 
tunnel syndrome showed a decrease of the sensory 
NCVs and an increase of the distal lateneies. 
The amplitudes of the sensory nerve action 
potential did not increase significantly. 
Graft rejection 
After kidney graft rejection symptoms reoccurred in 
30 % of the patients. The mean decrease of peroneal 
nerve conduction velocity after 1 year was 10.2 m/s 
and of the motor median nerve conduction velocity 
9.2 m/s (Fig. 2). Due to the small number of patients 
this was not statistically significant. 
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Fig. 3: Peroneal and median NCVs following pancreas graft 
rejection (* = p < 0.05, n.s. = p > 0.05)(o = median motor 
nerve, o = peroneal motor  nerve) 
Despite the fact, that in some patients nerve 
conduction velocities improved during the ftrst year 
following pancreas graft rejection, in all but one 
patient a decrease of NCVs occurred at variable 
intervals after the loss of graft function. Comparing 
the peroneal NCV before pancreas graft rejection or 
the maximum NCV following graft rejection in those 
cases who continued to improve despite loss of 
pancreas function, to the NCV at the end of the 
study, there was a statistically significant decrease of 
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6.5 m/s (p < 0.002). The worsening of the NCVs 
began at very different intervals from the time of 
rejection (0 to 51 months). 
Discussion 
Following simultaneous pancreas and kidney graft 
transplantation symptoms of polyneuropathy 
improved in our group of patients whereas 
neurological signs remained unchanged. In contrast 
to the natural course of diabetic peripheral 
neuropathy (Boulton et al. 1983) subjective claims of 
our patients, even those existing before the 
manifestation of uraemia, improved markedly. It is 
undecided, whether this is only a psychological effect 
or really a change of nerve function. Concerning the 
neurological status our data confirm the results of a 
previous study examining the effect of isolated 
pancreas transplantation in nonuraemic diabetic 
patients (Van der Vliet et al. 1988). 
The fact that we did not observe any change of 
neurological signs may be due to two different 
reasons: 
1) it may indicate, that the structural esion in 
diabetes is irreversible. 
2) changes may be too small to be seen within the 
follow-up period. Unfortunately there is a 
methodological problem to be overcome: using 
sophisticated methods to assess sensory and motor 
deficits such as psychophysic testing of thermal or 
pain thresholds there is a great intraindividnal 
variation due to factors such as alertness and 
cooperation. The more precise a clLnical examination 
protocol is, the less reliable it is (American Diabetes 
Association 1988). Using a simple grading of 
neuropathic signs small changes cannot be seen. 
Nerve conduction velocities of the upper and lower 
extremities increased significantly in our study. The 
same results have been obtained in three other 
studies (Van der Vliet et al. 1988; Solders et al. 1987; 
Kennedy et al. 1990). In both studies the authors 
compared the NCVs before transplantation to that 2 
years after transplantation. 
In contrast to these studies we took the status after 
the transplantation as a baseline for the following 
reasons: 
1) changes between the status before and after 
transplantation may be only, or to a large extent, the 
result of resolving uraemia. Because the type and 
severity of polyneuropathy differ between diabetic 
and non-diabetic patients (Solders et al. 1987), using 
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non-diabetic kidney transplanted patients as a control 
cannot solve this problem. 
2) The time interval between pre-transplant 
examination and transplantation varies widely since 
patients were examined neurologically some weeks 
or 1 to 2 years prior to transplantation. The severity 
of polyneuropathy changes unpredictably during this 
time. 
The fact that nerve conduction velocities improved 
over a period of three years, as we have shown in our 
study, indicates that there may be a structural change 
of the nerve. On the other hand the amplitudes of 
sensory nerve action potentials, which correlate to 
the number of axons of the nerve, remained 
unchanged. Reinnervation of denervated nerves was 
not observed except in one case. These results 
confirm the data of van der Vliet et al (1988) and this 
may indicate that the axonal dammage is irreversible 
while there is some change of the myelin sheath. 
The effect of graft rejection has not been examined 
as yet by other groups. As far as our data show, 
rejection of the kidney leads to a rather immediate 
decrease of nerve conduction velocities. The fact that 
the maximal change is seen within a few mouths may 
indicate that this is caused by functional rather than 
by morphological changes. 
The opposite was seen in patients with loss of 
function of the pancreas graft. There was no short- 
term effect but a decrease of nerve conduction 
velocity at variable intervals after rejection. 
Thus, our data as well as the data mentioned above 
suggest that strict normalization of glucose 
metabolism alters the progressive course of diabetic 
polyneuropathy. 
In conclusion, we believe that polyneuropathy may 
be stabilized or partly reversed after successful 
grafting even in long-term-diabetic patients. 
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